Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

IgA vasculitis renal involvement

Paediatrics and child health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Severe abdominal or renal complication

Intussusception, gastrointestinal bleeding, hypertensive encephalopathy, rapidly progressive glomerulonephritis, pulmonary haemorrhage and neurological vasculitis are rare but time critical. Severe colicky pain may precede obvious bleeding.

Action: Admit urgently, involve paediatrics and nephrology, monitor blood pressure and urine output, obtain FBC, renal profile, albumin, urine microscopy and protein quantification, and arrange targeted abdominal imaging for colicky pain or bleeding. Treat shock, AKI and hypertension through paediatric emergency pathways and obtain surgical review for suspected intussusception.

Synopsis

Recognise IgA vasculitis clinically, detect delayed renal involvement through systematic urine and blood-pressure surveillance, manage gastrointestinal and renal red flags, and refer proteinuria, hypertension or impaired function promptly.

  • IgA vasculitis is an IgA-mediated small-vessel vasculitis, formerly called Henoch–Schönlein purpura, most common in children under 10 years.
  • The diagnostic pattern is palpable non-thrombocytopenic purpura, usually on buttocks and lower limbs, plus one or more of abdominal pain, arthritis or arthralgia, renal involvement or IgA-predominant histology.
  • Renal involvement may be silent and delayed. It ranges from microscopic haematuria to proteinuria, hypertension, nephritic or nephrotic syndrome and rapidly progressive kidney injury.
  • First-line assessment includes blood pressure plotted for age, sex and height, urinalysis for blood and protein, and urine protein:creatinine or albumin:creatinine ratio when either is positive.
  • Check FBC when diagnosis is uncertain to demonstrate a normal platelet count, and renal profile and albumin when urine, blood pressure or systemic severity is abnormal.
  • A normal first urinalysis does not end surveillance. The NHSGGC pathway checks blood pressure and urine at 1 week, 1 month, 3 months, 6 months and 12 months when results remain normal.
  • An alternative widely used NHS schedule is weekly urine and blood pressure for 6 weeks then monthly to 6 months; follow the local pathway consistently and extend review whenever abnormalities occur.
  • Isolated microscopic haematuria usually needs continued surveillance rather than immunosuppression. Proteinuria magnitude, hypertension and eGFR determine renal urgency.
  • First-line management for uncomplicated skin and joint disease is hydration, rest as needed and paracetamol. Avoid NSAIDs when renal involvement, bleeding, dehydration or abdominal complications are possible.
  • Corticosteroids may reduce severe abdominal or joint symptoms but do not reliably prevent later nephritis; do not prescribe them solely to protect normal kidneys.
  • Persistent or increasing proteinuria, nephrotic syndrome, hypertension or reduced function requires paediatric nephrology, possible biopsy and disease-specific renin–angiotensin blockade or immunosuppression.
  • Most children recover fully, but renal prognosis is determined by kidney involvement rather than rash severity; maintain surveillance even after purpura and pain resolve.

Key red flags

Severe colicky abdominal pain, bilious vomiting, bloody stool, abdominal mass or lethargy suggests intussusception or bowel ischaemia.

Hypertension, reduced urine output, oedema, macroscopic haematuria or rising creatinine indicates significant IgA vasculitis nephritis.

Nephrotic-range proteinuria, serum albumin below 30 g/L or rapidly increasing proteinuria requires urgent nephrology assessment.

eGFR below 60 mL/min/1.73 m², rapidly deteriorating function or hypertensive neurological symptoms requires admission and immediate specialist management.

Purpura with thrombocytopenia, coagulopathy, shock or meningism is not a typical uncomplicated IgA vasculitis phenotype and requires an alternative emergency pathway.

Pulmonary haemorrhage, seizure, confusion or focal neurological change is rare but requires intensive multidisciplinary care.

Investigation priorities

01
First-line: blood pressure and urinalysisFirst stepFirst line

Detect clinically silent renal involvement at diagnosis and throughout follow-up.

Management branches

PresentationConfirm phenotype and severity

Palpable dependent purpura suggests possible IgA vasculitis.

  1. Assess sepsis, abdominal emergency and neurological red flags before accepting a benign vasculitis course.
  2. Measure blood pressure, urinalysis and height; quantify protein and check renal function when abnormal.
  3. Provide symptom care and a written renal-surveillance schedule even when initial urine and pressure are normal.

Key medicines

ParacetamolFor pain in a child aged at least 3 months, use 15 mg/kg orally every 4 to 6 hours when needed, maximum 4 doses in 24 hours and maximum 1 g per dose; use current BNFC age and weight limits.Check all combination products, weight, liver disease, malnutrition and dosing interval. Pain requiring repeated maximum doses, severe abdominal pain or functional deterioration needs clinical reassessment rather than analgesic escalation.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NHSGGC IgA vasculitis renal pathwayBlood-pressure, urine and protein thresholds, surveillance schedule and referral.
  • NHSGGC non-blanching rash guidelineIgA vasculitis phenotype and dangerous alternative diagnoses.
  • InfoKID IgA vasculitisCurrent UK paediatric overview, kidney involvement, investigations and outcomes.
  • InfoKID IgA vasculitis treatmentRenal monitoring, symptom treatment and specialist care for significant nephritis.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom